1.Normal reference values and predict equations of heart function.
Zhi-nan LU ; Sun XING-GUO ; Song-shou MAO ; M J BUDOFF ; W W STRINGER ; Wan-gang GE ; Hao LI ; Jie HUANG ; Fang LIU ; Sheng-shou HU
Chinese Journal of Applied Physiology 2015;31(4):332-336
OBJECTIVEFor heart functional parameters, we commonly used normal range. The reference values and predict formulas of heart functional parameters and their relationships with individual characteristics are still lack.
METHODSLeft ventricular (LV) volumes (end-diastolic volume and end-systolic volume), stroke volume (SV), ejection fraction (EF) and cardiac output (CO) were measured by cardiac CT angiography (CAT) in 1 200 healthy Caucasian volunteers, men 807 and women 393, and age 20-90yr. The results are analyzed by high-accuracy three-dimensional imaging technology, and then measured the dynamic changes of the volumes of each atriam and ventricule during their contractions and relaxations. The gender, age, height and weight were analyzed by multiple linear regression to predict LV functional parameters.
RESULTSExcept the LVEF was lower in man than in women (P < 0.001), all other LV functional parameters of EDV, ESV, SV, FE and CO were higher in man (P < 0.001). Multiple linear regression indicated that age, gender, height and weight are all independent factors of EDV, ESV and SV (P < 0.001). CO could be significantly predicted by age, gender and weight (P < 0.001), but not height (P > 0.05). The predict equation for CO (L x min(-1)) = 6.963+0.446 (Male) -0.037 x age (yr) +0.013 x weight (kg).
CONCLUSIONAge, gender, height and weight are predictors of heart functions. The reference values and predict equations are important for noninvasive and accurate evaluation of cardiovascular disease and individualized treatment.
Adult ; Age Factors ; Aged ; Aged, 80 and over ; Body Height ; Body Weight ; Cardiac Output ; Female ; Heart ; physiology ; Humans ; Male ; Middle Aged ; Reference Values ; Sex Factors ; Stroke Volume ; Ventricular Function, Left ; Young Adult
2.Surgical treatment for vascular anomalies and tracheoesophageal compression.
Song BAI ; Xiao-feng LI ; Cai-xia LIU ; Yun PENG ; Feng YUAN ; Jian GUO ; Zhen-jiang SONG ; William M NOVICK ; Zhong-zhi LI
Chinese Medical Journal 2012;125(8):1504-1507
BACKGROUNDVascular rings are uncommon anomalies in which preferred strategies for diagnosis and management may vary among institutions. In this study, we reported our approach and a review of our 5-year experience.
METHODSFrom May 2006 to April 2011, 45 children (31 boys) with vascular rings underwent surgical repair at Beijing Children's Hospital. Nineteen patients (26%) had associated heart anomalies.
RESULTSThere were two hospital deaths. At follow-up, 11 patients still had intermittent respiratory symptoms, but these symptoms had no effect on growth or physical activities. No patients required reoperation.
CONCLUSIONSThe rates of misdiagnosis and missed diagnosis of vascular rings are higher than those of other congenital heart diseases. A high index of clinical suspicion coupled with the use of computed tomography enables early diagnosis. Surgical repair can be performed successfully, although a number of patients will have persistent symptoms.
Child, Preschool ; Female ; Humans ; Infant ; Male ; Tracheal Stenosis ; mortality ; surgery ; Vascular Malformations ; diagnosis ; mortality ; surgery
3.Modeling and simulation activities to design sampling scheme for population pharmacokinetic study on amlodipine.
Xiao-Cong ZUO ; Hong YUAN ; Bi-Kui ZHANG ; Chee M NG ; Jeff S BARRETT ; Guo-Ping YANG ; Zhi-Jun HUANG ; Qi PEI ; Ren GUO ; Ya-Nan ZHOU ; Ning-Ning JING ; Wu DI
Acta Pharmaceutica Sinica 2012;47(7):941-946
Reasonable sampling scheme is the important basis for establishing reliable population pharmacokinetic model. It is an effective method for estimation of population pharmacokinetic parameters with sparse data to perform population pharmacokinetic analysis using the nonlinear mixed-effects models. We designed the sampling scheme for amlodipine based on D-optimal sampling strategy and Bayesian estimation method. First, optimized sample scenarios were designed using WinPOPT software according to the aim, dosage regimen and visit schedule of the clinical study protocol, and the amlodipine population model reported by Rohatagi et al. Second, we created a NONMEM-formatted dataset (n = 400) for each sample scenario via Monte Carlo simulation. Third, the estimation of amlodipine pharmacokinetic parameters (clearance (CL/F), volume (V/F) and Ka) was based on the simulation results. All modeling and simulation exercises were conducted with NONMEM version 7.2. Finally, the accuracy and precision of the estimated parameters were evaluated using the mean prediction error (MPE) and the mean absolute error (MAPE), respectively. Among the 6 schemes, schemes 6 and 3 have good accuracy and precision. MPE is 0.1% for scheme 6 and -0.6% for scheme 3, respectively. MAPE is 0.7% for both schemes. There is no significant difference in MPE and MAPE of volume among them. Therefore, we select scheme 3 as the final sample scenario because it has good accuracy and precision and less sample points. This research aims to provide scientific and effective sampling scheme for population pharmacokinetic (PK) study of amlodipine in patients with renal impairment and hypertension, provide a scientific method for an optimum design in clinical population PK/PD (pharmacodynamics) research.
Adult
;
Age Factors
;
Alanine Transaminase
;
blood
;
Amlodipine
;
pharmacokinetics
;
pharmacology
;
Antihypertensive Agents
;
pharmacokinetics
;
pharmacology
;
Bayes Theorem
;
Body Weight
;
Calcium Channel Blockers
;
pharmacokinetics
;
pharmacology
;
Humans
;
Hypertension
;
metabolism
;
Metabolic Clearance Rate
;
Middle Aged
;
Models, Biological
;
Monte Carlo Method
;
Nonlinear Dynamics
;
Renal Insufficiency
;
metabolism
;
Software
4.Herbalogical study on olibanum(Ruxiang).
Zi-Han HUANG ; W U MENG-HUA ; Si-Min LUO ; Yu ZHOU ; Ying ZHANG ; M A ZHI-GUO ; Hui CAO
China Journal of Chinese Materia Medica 2020;45(21):5296-5303
As a representative foreign medicinal material, olibanum(Ruxiang) was imported to China since the Qin and Han Dynasties. Olibanum was first described as a medicinal by the name "Xunluxiang" in Miscellaneous Records of Famous Physicians(Ming Yi Bie Lu). This study investigated historical records on olibanum and conducted the herbalogical study. It was found that olibanum came from the resin mainly obtained from the bark of Pistacia lenticus before the Tang Dynasty. With the prosperity of the Maritime Silk Road, instead, the resin obtained from the bark of Boswellia carterii was mainly used as olibanum. In ancient time, the oleo-gum-resin secreted from the cut bark was collected in spring and summer, and the quality was judged based on transparency and shape. The processing methods of olibanum went through many evolutions, which changed from simple methods such as grinding and frying to complex methods such as levigating and grinding with wine, and now to frying and processing with vinegar. The usage of olibanum included alchemy, folk and religious incense, bathing, cosmetic and medicinal since ancient times. From the Song Dynasty, olibanum had been mainly used as medicinal because of its good effect to treat wounds. In traditional Chinese medicine, olibanum unblocks menstruation, relieves pain and reduces swelling and generated muscles. The medicinal efficacy of olibanum is not much different from ancient to modern. Only the efficacy of replenishing energy and promoting the movement of Qi was rarely mentioned in modern reference. In this article, the historical evolutions of olibanum about original plants, processing and medicinal efficacy were sorted out. The results could provide historical basis for the further development and clinical utilization of olibanum.
China
;
Drugs, Chinese Herbal
;
Frankincense
;
Medicine, Chinese Traditional
;
Resins, Plant